Advanced Medical Institute (AMI)
Advanced Medical Institute (AMI), headquartered in Sydney, Australia, is a leading provider of treatment programs for erectile dysfunction and premature ejaculation in Australia and New Zealand. The Company operates more than 20 facilities in Australasia, China and Japan. Advanced Medical Institute (AMI) has more than 280 employees, including 57 medical personnel and, since its inception, has provided treatment to more than 350,000 customers. Advanced Medical Institute (AMI) and its predecessor companies began arranging treatment programs for Premature Ejaculation and Erectile Dysfunction patients in 1993.
Advanced Medical Institute (AMI) is the patent holder and sole global supplier of no needles – no tablets 'Deep-Lung, High-Density Aerosol Drug Delivery technologies' treating sexual dysfunction in men.
Advanced Medical Institute (AMI), a leading provider of treatment for Erectile Dysfunction and Premature Ejaculation in Australia and New Zealand, will expand its operations into the United Kingdom on September 15, 2008, it was announced today by Dr. Jack Vaisman, Chairman, Chief Executive Officer, Founder and President of AMI Australia and its chief operating subsidiary, AMI Australia Holdings Pty Limited.
Advanced Medical Institute (AMI) focuses on delivering safe, faster acting and lower dosage treatments to people suffering from erectile dysfunction and premature ejaculation. Unlike many of our competitors, we treat the whole patient, individually and over the long term. AMI Australia strategy is to provide new methods of treatment and delivery systems that provide a practical non-invasive method of drug delivery to the body to treat premature ejaculation and erectile dysfunction marketed directly to the public. In addition to Australia, Advanced Medical Institute (AMI) treatment programs are available in New Zealand, China, Japan, Indonesia and Europe.
AMI nasal Spray developed and patented by the Advanced Medical Institute (AMI) of Australia. AMI are also based in New Zealand and now Europe under amieurope.co.uk. The nasal sprays developed by this company have been under a lot of scrutiny lately and this adds to all the controversy the company as a whole has attracted since its inception in Australia. Advanced Medical Institute (AMI) will now conduct business in the UK through its wholly owned subsidiary, AMI Clinic Limited (AVMD UK).
